STK11 and non-small cell lung carcinoma: Lamberti et al. in a study of NSCLC, which included 909 patients with most non-squamous histology and advanced stage cases, demonstrated that tumours with negative PD-L1 expression, compared to those with high PD-L1 expression, were associated with mutations in STK11 [41].